NPPB and chronic obstructive pulmonary disease: Patients therapeutically anticoagulated had a higher prevalence of COPD and presented with high D-dimer, LDH, and BNP values; and low lymphocyte count and PaO2 indicative of more severe COVID-19 disease [25–27], which may explain the high mortality rate among therapeutically anticoagulated patients.